Hauptinhalt

Publikationen 2018

Fachzeitschriften

  1. Acosta H, Jansen A, Nuscheler B, Kircher T. A voxel-based morphometry study on adult attachment style and affective loss. Neuroscience 2018, 392:219-229.
  2. Baron F, Mehl S. Zwangsmaßnahmen in der Psychiatrie? Datenlage und präventive Möglichkeiten. Forum Sozialarbeit und Gesundheit 2018, 2:20-28.
  3. Berger P, Bitsch F, Nagels A, Straube B, Falkenberg I. Frontal hypoactivation and alterations in the reward-system during humor processing in patients with schizophrenia spectrum disorders. Schizophrenia Research 2018, 202:149-157.
  4. Berger P, Bitsch F, Nagels A, Straube B, Falkenberg I. Personality modulates amygdala and insula connectivity during humor appreciation: An event-related fMRI study. Social Neuroscience 2018, 13:756-768.
  5. Besteher B, Squarcina L, Spalthoff R, Bellani M, Gaser C, Nenadić I, Brambilla P. Subclinical Agoraphobia Symptoms and Regional Brain Volumes in Non-clinical Subjects: Between Compensation and Resilience? Frontiers in Psychiatry 2018, 9:541.
  6. Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium. Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes. Cell 2018, 173:1705-1715.e16.
  7. Bitsch F, Berger P, Nagels A, Falkenberg I, Straube B. The role of the right temporo-parietal junction in social decision-making. Human Brain Mapping 2018, 1-14.
  8. Bodenschatz CM, Skopinceva M, Kersting A, Quirin M, Suslow T. Implicit negative affect predicts attention to sad faces beyond self-reported depressive symptoms in healthy individuals: An eye-tracking study. Psychiatry Research 2018, 265:48-54.
  9. Brainstorm Consortium, Anttila V, …, Nenadic I, ... , Murray R. Analysis of shared heritability in common disorders of the brain. Science 2018, 360(6395).
  10. Fusar-Poli P, De Micheli A, Rocchetti M, Cappucciati M, Ramella-Cravaro V, Rutigliano G, Bonoldi I, McGuire P, Falkenberg I. Semistructured Interview for Bipolar At Risk States (SIBARS). Psychiatry Research 2018, 264:302-309.
  11. Gebhardt S, Dammann I, Loescher K, Wehmeier PM, Vedder H, von Georgi R. The effects of music therapy on the interaction of the self and emotions - An interim analysis. Complementary Therapies in Medicine 2018, 41:61–66.
  12. Hansmeier J, Exner C, Zetsche U, Jansen A. The Neural Correlates of Probabilistic Classification Learning in Obsessive-Compulsive Disorder: A Pilot Study. Frontiers in Psychiatry 2018, 9:58.
  13. He Y, Steines M, Sommer J, Gebhardt H, Nagels A, Sammer G, Kircher T, Straube B. Spatial-temporal dynamics of gesture-speech integration: a simultaneous EEG-fMRI study. Brain Structure and Function 2018, 223:3073-3089.
  14. He Y, Steines M, Sammer G, Nagels A, Kircher T, Straube B. Action-Related Speech Modulates Beta Oscillations During Observation of Tool-Use Gestures. Brain Topography 2018, 223:3073-3089.
  15. Hommers LG, Richter J, Yang Y, Raab A, Baumann C, Lang K, Schiele MA, Weber H, Wittmann A, Wolf C,  Alpers GW, Arolt V, Domschke K, Fehm L, Fydrich T, Gerlach A, Gloster AT, Hamm AO, Helbig-Lang D, Kircher T, Lang T, Pané-Farré CA, Pauli P, Pfleiderer B, Reif A, Romanos M, Straube B, Ströhle A, Wittchen HU, Frantz S, Ertl G, Lohse MJ, Lueken U, Deckert J. A functional genetic variation of SLC6A2 repressor hsa-miR-579-3p upregulates sympathetic noradrenergic processes of fear and anxiety. Translational Psychiatry 2018, 8:226.
  16. Karrasch M, Fingerle V, Boden K, Darr A, Baier M, Straube E, Nenadic I. Neuroborreliosis and acute encephalopathy: The use of CXCL13 as a biomarker in CNS manifestations of Lyme borreliosis. Ticks and Tick-borne Diseases  2018, 9:415-417.
  17. Kircher T, Bröhl H, Meier F, Engelen J. Formal Thought Disorders (FTD): From Phenomenology to Neurobiology. Lancet Psychiatry 2018, 5:515-526.
  18. Kong XZ, Mathias SR, Guadalupe T, ENIGMA Laterality Working Group [ … Kircher T, … Krug A, …], Glahn DC, Franke B, Crivello F, Tzourio-Mazoyer N, Fisher SE, Thompson PM, Francks C. Mapping cortical brain asymmetry in 17,141 healthy individuals worldwide via the ENIGMA Consortium. Proceedings of the National Academy of Sciences of the United States of America 2018, 115:E5154-E5163.
  19. Kraus C, Vanicek T, Weidenauer A, Khanaqa T, Stamenkovic M, Lanzenberger R, Willeit M, Kasper S. DiGeorge syndrome - Relevance of psychiatric symptoms in undiagnosed adult patients. Wiener klinische Wochenschrift 2018, 130:283–287.
  20. Krautheim J, Straube B, Dannlowski U, Pyka M, Schneider-Haßloff H, Drexler R, Krug A, Sommer J, Rietschel M, Witt SH, Kircher T. Outgroup Emotion Processing in the vACC is modulated by Childhood Trauma and CACNA1C Risk Allele. Social Cognitive and Affective Neuroscience 2018, 13:341-348.
  21. Krug A, Dietsche B, Zöllner R, Yüksel D, Nöthen MM, Forstner AJ, Rietschel M, Dannlowski U, Baune BT, Maier R, Witt SH, Kircher T. Polygenic risk for schizophrenia affects working memory and its neural correlates in healthy subjects. Schizophrenia Research 2018, 197:315-320.
  22. Künzel H, Held K, Schmidt D, Ziegenbein M, Murck H, Steiger A. Sleep-endocrine effects of growth hormone-releasing hormone (GHRH) in patients with schizophrenia. Journal of Psychiatric Research 2018, 101:1-4.
  23. Lamster F, Kiener J, Wagner K, Rief W, Görge SC, Iwaniuk I, Leube D, Falkenberg I, Kluge I, Kircher T, Mehl S. Ist Wahn indirekt veränderbar? Ein stimmungsverbesserndes Konzept der kognitive Verhaltenstherapie für die stationäre Standardversorgung von Patienten mit schizophrenen Störungen. Verhaltenstherapie 2018, 28:138-146.
  24. LeWitt PA, Pahwa R, Sedkov A, Corbin A, Batycky R, Murck H. Pulmonary Safety and Tolerability of Inhaled Levodopa (CVT-301) Administered to Patients with Parkinson's Disease. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2018, 31:155-161.
  25. Mehl S. Kognitiven Verzerrungen und Wahn wirksam begegnen: individualisiertes Metakognitives Therapieprogramm für Menschen mit Psychose. Zeitschrift für Klinische Psychologie und Psychotherapie 2018, 47:209-211.
  26. Müller H, de Millas W, Gaebel W, Herrlich J, Hasan A, Janssen B, Juckel G, Karow A, Kircher T, Kiszkenow-Bäker S, Klingberg S, Klosterkötter J, Krüger-Özgürdal S, Lambert M, Lautenschlager M, Maier W, Michel TM, Mehl S, Müller BW, Pützfeld V, Rausch F, Riedel M, Sartory G, Schneider F, Wagner M, Wiedemann G, Wittorf A, Wobrock T, Wölwer W, Zink M, Bechdolf A. Negative schemata about the self and others and paranoid ideation in at-risk states and those with persisting positive symptoms. Early Intervention in Psychiatry 2018, 12:1157-1165.
  27. Murck H, Ploch M, Montgomery S. Mineralocorticoid receptor-related markers and outcome of major depression: focus on blood pressure and electrolytes. International Clinical Psychopharmacology 2018, 33:224-228.
  28. Nagels A, Cabanis M, Oppel A, Kirner-Veselinovic A, Schales C, Kircher T. S-Ketamine-Induced NMDA Receptor Blockade During Natural Speech Production and its Implications for Formal Thought Disorder in Schizophrenia: A Pharmaco-fMRI Study. Neuropsychopharmacology 2018, 43:1324-1333.
  29. Ni G, Gratten J, Wray NR, Lee SH, Schizophrenia Working Group of the Psychiatric Genomics Consortium. Age at first birth in women is genetically associated with increased risk of schizophrenia. Scientific Reports 2018, 8:10168.
  30. Ni G, Moser G, Schizophrenia Working Group of the Psychiatric Genomics Consortium, Wray NR, Lee SH. Estimation of Genetic Correlation via Linkage Disequilibrium Score Regression and Genomic Restricted Maximum Likelihood. American Journal of Human Genetics 2018, 102:1185-1194.
  31. Pedrosa Carrasco AJ, Timmermann L, Pedrosa DJ. Management of constipation in patients with Parkinson's disease. NPJ Parkinsons Disease 2018, 4:6.
  32. Perlini C, Bellani M, Besteher B, Nenadić I, Brambilla P. The neural basis of hostility-related dimensions in schizophrenia. Epidemiology and Psychiatric Sciences 2018, 27:546-551.
  33. Riehle M, Mehl S, Lincoln TM. The specific social costs of expressive negative symptoms in schizophrenia: reduced smiling predicts interactional outcome. Acta Psychiatrica Scandinavica 2018, 138:133-144.
  34. Seeger F, Yang Y, Straube B, Kircher T, Höfler M, Wittchen HU, Ströhle A, Wittmann A, Gerlach AL, Pfleiderer B, Arolt V, Hamm A, Lang T, Alpers GW, Fydrich T, Lueken U. Clinical and Neurofunctional Substrates of Cognitive Behavioral Therapy on Secondary Social Anxiety Disorder in Primary Panic Disorder: A Longitudinal fMRI Study. Psychotherapy and Psychosomatics 2018, 1-4.
  35. Spalthoff R, Gaser C, Nenadić I. Altered gyrification in schizophrenia and its relation to other morphometric markers. Schizophrenia Research 2018, 202:195-202.
  36. Van Kemenade BM, Arikan BE, Podranski K, Steinsträter O, Kircher T, Straube B. Distinct roles for the cerebellum, angular gyrus and middle temporal gyrus in action-feedback monitoring. Cerebral Cortex 2018, 1-12.
  37. Via Fullana MA, Goldberg X, Tinoco-González D, Martínez-Zalacaín I, Soriano-Mas C, Davey CG, Menchón JM, Straube B, Kircher T, Pujol J, Cardoner N, Harrison BJ. Deficient ventromedial prefrontal cortex activity characterizes pathological worry in generalized anxiety disorder. British Journal of Psychiatry 2018, 213:437-443.
  38. Vogelbacher C, Möbius TWD, Sommer J, Schuster V, Dannlowski U, Kircher T, Dempfle A, Jansen A, Bopp MHA. The Marburg-Münster Affective Disorders Cohort Study (MACS): A quality assurance protocol for MR neuroimaging data. Neuroimage 2018, 172:450–460.
  39. Wendt J, Hamm AO, Pané-Farré CA, Thayer JF, Gerlach A, Gloster AT, Lang T, Helbig-Lang S, Pauli P, Fydrich T, Ströhle A, Kircher T, Arolt V, Deckert J, Wittchen HU, Richter J. Pre-treatment cardiac vagal tone predicts dropout from and residual symptoms after exposure therapy in patients with panic disorder and agoraphobia. Psychotherapy and Psychosomatics 2018, 87:187-189.
  40. Wittmann A, Schlagenhauf F, Guhn A, Lueken U, Elle M, Stoy M, Liebscher C, Bermpohl F, Fydrich T, Pfleiderer B, Bruhn H, Gerlach AL, Straube B, Wittchen HU, Arolt V, Heinz A, Kircher T, Ströhle A. Effects of Cognitive Behavioral Therapy on Neural Processing of Agoraphobia-Specific Stimuli in Panic Disorder and Agoraphobia. Psychotherapy and Psychosomatics 2018, 87:350-365.
  41. Yüksel D, Dietsche B, Konrad C, Dannlowski U, Kircher T, Krug A. Neural correlates of working memory in first episode and recurrent depression: an fMRI study. Progress in Neuropsychopharmacology & Biological Psychiatry 2018, S0278-5846(17)30797-2.
  42. Yüksel D, Engelen J, Schuster V, Dietsche B, Konrad C, Jansen A, Dannlowski U, Kircher T, Krug A. Longitudinal brain volume changes in major depressive disorder. Journal of Neural Transmission (Vienna) 2018, 125:1433-1447.
  43. Zaremba D, Enneking V, Meinert S, Förster K, Bürger C, Dohm K, Grotegerd D, Redlich R, Dietsche B, Krug A, Kircher T, Kugel H, Heindel W, Baune BT, Arolt V, Dannlowski U. Effects of cumulative illness severity on hippocampal gray matter volume in major depression: a voxel-based morphometry study. Psychological Medicine 2018, 48:2391-2398.
  44. Zavorotnyy M*, Zöllner R* (*equal contribution), Schulte-Güstenberg LR, Wulff L, Schöning S, Dannlowski U, Kugel H, Arolt V, Konrad C. Low left amygdala volume is associated with a longer duration of unipolar depression. Journal of neural transmission (Vienna) 2018, 125:229-238.

Bücher

  1. Kircher T. (Hrsg) Kompendium der Psychotherapie. Springer Verlag, Heidelberg Berlin, 2019 (Erscheinungsdatum: 15.11.2018). ISBN 978-3-662-57286-3 .

Buch Kapitel

  1. Nagels A, Kelly SD, Kircher T, Straube B. Hand Gestures Alert Auditory Cortices. (S. 53-66) In: Zlatkin-Troitschanskaia O, Wittum G, Dengel A (Hrsg). Positive Learning in the Age of Information. Springer VS, Wiesbaden, 2018.